SpringWorks Therapeutics

Director, Value, Access & Pricing- US Rare Tumors (GOMEKLI)

SpringWorks Therapeutics$167K — $270K *
US-AnywhereRemote in United States
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in business or related field; MBA or advanced degree preferred
  • 9+ years in pharmaceutical/biotech, specifically rare disease or oncology
  • 5+ years in internal market access roles
  • Experience with internal rare disease/oncology product launches and cross-functional brand teams
  • Value/payer marketing and customer insights skills required
  • Field/payer experience and new product pricing are pluses
  • Understanding of Oncology value frameworks and patient advocacy is advantageous

Responsibilities

  • Serve as the market access expert for GOMEKLI, guiding cross-functional teams on strategic developments
  • Develop market access strategies and evidence-based payer value propositions to influence coverage decisions
  • Lead creation of resources for field teams, ensuring they are equipped for effective engagement
  • Shape pricing and contracting strategies to enhance competitiveness and patient access
  • Manage the pricing lifecycle while ensuring compliance with regulations
  • Monitor market dynamics to adapt strategies related to pricing and public policy
  • Build and maintain strategic partnerships to achieve project goals and adhere to budgets

Benefits

  • Best-in-class benefits including health, dental, and vision insurance
  • 401(k) plan with company match options
  • Generous paid time off and holiday policies
  • Flexible working arrangements with remote opportunities
  • Professional development and continued education support
Full Job Description
Your Role:

The Director, Value, Access & Pricing (VAP) GOMEKLI is a critical leadership role within the U.S. Market Access team, responsible for shaping the strategic direction and leading the development and execution of market access and pricing strategies to support the commercial success of GOMEKLI.

This individual will lead the development of access strategies and tactics that communicate the differentiated value of GOMEKLI to key external stakeholders-including payers, C-suite executives, provider networks, GPOs, pharmacists, and population-based decision-makers in community oncology. The Director will be accountable for delivering a suite of payer and provider-facing tools, field team resources, and non-personal engagement tactics to ensure optimal access and uptake.

The Director will collaborate closely with cross-functional partners including brand marketing, sales, HEOR, medical affairs, patient services, and operations to ensure strategic alignment and execution excellence. This position reports to the Executive Director, Value, Access & Pricing - Rare Tumors and works in close partnership with the broader U.S. Market Access.

This role is open for remote consideration #LI-Remote

This role is preferred hybrid: work onsite 3 days a week at our Seaport office

Essential Duties and Responsibilities:
  • Act as the product-specific market access expert and central hub for all access-related topics, serving as the primary point of contact for cross-functional teams and informing the broader U.S. Market Access organization on product-specific developments, strategies, and insights
  • Leads the development of Market Access strategies and evidence-based payor value proposition; manages the execution of brand aligned Market Access tactical plans that influence coverage decisions and remove patient access hurdles
  • Leads strategic and tactical development and pull through of various field-based resources to support field facing teams including Strategic Enterprise Account Directors (SEADs), Field Access Managers (FAMs), and Sales teams
  • Shapes the development of pricing and contracting strategies, ensuring market competitiveness, payor acceptance and coverage policies that enable patient access
  • Manage Pricing and Government Pricing annual lifecycle, including both strategic and operational activities to maintain compliance with regulations
  • Continuously evaluates changing market and competitive dynamics to inform short and long-term strategies including but not limited to formulary positioning, contracting, pricing, real-world evidence generation and public policy
  • Leads the management of key strategic partner relationships to ensure execution of the strategic vision and tactical goals as well as the timely completion of projects within budget
  • Monitor evolving reimbursement and policy landscape and integrate insights into access strategy
  • Measure and report impact of targeted launch / access tactical plan investments

Role Requirements:

Education:
  • Bachelor's degree (business or related disciplines)
  • MBA or other advanced degree preferred

Skills/Experience:
  • 9+ years of pharmaceutical and/or biotech experience required in rare disease or Oncology
  • 5+ years in internal Market access role
  • Internal rare disease/oncology launch experience required (strategic, operational and tactical)
  • Inline rare disease/oncology product market access and cross-functional brand team experience required
  • Value/payer marketing and customer insights generation experience required
  • Field and/or field payer experience preferred
  • New Product Pricing experience preferred
  • Understanding of Oncology value frameworks, HeOR, pricing, policy and patient advocacy preferred
  • Experience in patient administered products (Part D, oral)
  • Experience working a collaborative, dynamic, accountable environment

Technical:
  • Expert in US market access environment with knowledge of recent policy changes, external product launches and current dynamics in Rare & Oncology

Other:
  • Collaborative and curious, with innovative drive and continuous improvement mindset
  • Ability to travel to market access internal and external customer-facing meetings 30-40%

Leadership:
  • Inclusive, humble, people-first leader with demonstrated examples of successful collaboration and engagement in a fast-moving environment

Communication:
  • Strong communication both written and verbal
  • Ability to influence up and across to achieve strategic objectives, gain alignment and secure resources

Preferred Qualifications:
  • Ability to communicate openly and share information to foster trust while encouraging constructive debate, making informed decisions, and ensuring shared commitment to outcomes.
  • Demonstrated willingness to take risks and stand up for what is right while prioritizing the needs and experiences of customers and patients in all decisions.
  • Commitment to setting and reaching ambitious goals and setting high standards while acting in the best interest of the company and taking initiative to drive results.
  • Uphold ethical standards and being honest in all interactions.
  • Ability to streamline processes to focus on what matters and creates impact and acting quickly to adapt to changes.
  • Demonstrated ability to embrace new ideas, challenge the status quo, and seek innovative solutions while valuing diverse perspectives and treating others with respect and dignity.

Compensation and Benefits:The expected salary range for this position is $167,000 - $270,000. Actual pay will be determined based on experience, qualifications, location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance.

We offer best-in-class benefits for our team of SpringWorkers who work with urgency on behalf of patients suffering from devastating diseases. Interested in learning more, review additional information here Benefits.

About SpringWorks Therapeutics

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for rare diseases and cancer. The company was founded in 2017 and is headquartered in Stamford, Connecticut. SpringWorks Therapeutics focuses on developing targeted therapies that address the underlying biology of diseases. The company's lead product candidate, nirogacestat, is being developed for the treatment of desmoid tumors, a rare and debilitating disease. SpringWorks Therapeutics has partnerships with several academic institutions and pharmaceutical companies, including Pfizer and BeiGene.
Learn more about SpringWorks Therapeutics
Size
190 employees
Market Cap
$1.4 billion
Industry
Net Income
-$45.5 million
Founded
2017
Revenue
$35 million
NASDAQ

Similar Jobs

More Jobs at SpringWorks Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Director, Value, Access & Pricing- US Rare Tumors (GOMEKLI) jobs: